Yüklüyor......
Current progress in stem cell therapy for type 1 diabetes mellitus
Type 1 diabetes mellitus (T1DM) is the most common chronic autoimmune disease in young patients and is characterized by the loss of pancreatic β cells; as a result, the body becomes insulin deficient and hyperglycemic. Administration or injection of exogenous insulin cannot mimic the endogenous insu...
Kaydedildi:
| Yayımlandı: | Stem Cell Res Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7346484/ https://ncbi.nlm.nih.gov/pubmed/32641151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01793-6 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|